Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05730920Phase 4Completed
Phase 4, randomised, single-blind trial of bupivacaine extended release liposome injection in postoperative pain (2 arms). Primary endpoint: Successful Enrollment and Data Collection of 30 Subjects at 2 years. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05730920.